1) anhydroleucovorin
脱水甲酰四氢叶酸
2) formyltetrahydrofolate deformylase
甲酰四氢叶酸脱甲酰酶
3) Leucovorin
[,lju:kə'vɔrin]
甲酰四氢叶酸钙
1.
Capecitabine in combination with leucovorin and oxaliplatin as adjuvant chemotherapy in the treatment of advanced colorectal cancer
卡培他滨联合甲酰四氢叶酸钙和奥沙利铂治疗晚期结直肠癌的临床观察
2.
Objective To evaluate the efficacy and safety of oxaliplat in combined with fluorouracil(5-FU) and leucovorin (LV) in the treatment of patie nts with advanced gastric cancer.
治疗组应用奥沙利铂 80mg/m2 静脉滴注第 1、8、15天 ,5 氟脲嘧啶 5 0 0mg/m2 静脉滴注第 1、8、15天 ,甲酰四氢叶酸钙 10 0mg/d静脉滴注第 1、8、15天。
4) Folinic acid
甲酰四氢叶酸
1.
Oxaliplatin combining fluorouracil and folinic acid in treatment of locally advanced and metastatic gastric cancer;
奥沙利铂联合5-氟尿嘧啶和甲酰四氢叶酸治疗晚期和复发性胃癌的临床分析
2.
BACKGROUND & AIM: To study the DNA damage of BALE/ c mice caused by multiple treatment with low-dose methotrexate (MTX)and the protective effect of folinic acid (FA).
背景与目的:研究多次低剂量应用甲氨蝶呤所致BALB/c小鼠淋巴细胞及骨髓细胞:DNA的损伤,并探讨甲酰四氢叶酸对其损伤的保护作用。
5) leucovorin
[,lju:kə'vɔrin]
甲酰四氢叶酸
1.
Methods A total of 48 advanced colctal cancer patients were enrolled into test,who were treated with oxaliplatin and LV/5FU for three cycles,which combine oxaliplatin 130 mg/m~2(d1) and LV/5FU [leucovorin(LV) 400mg/m~2 as a 2-hour infusion(d2),5-fluorouracil(5-FU) 3.
目的观察应用草酸铂联合氟尿嘧啶、甲酰四氢叶酸治疗晚期大肠癌的客观疗效及不良反应。
2.
Objective To observe the efficacy and safety of combination chemotherapy of Epidoxorubicin(EPI),Leucovorin(CF),5-Fluorouracil(5-Fu) and Cisplation(DDP) for gastric cancer.
目的观察表阿霉素(EPI)、甲酰四氢叶酸(CF)、5氟-尿嘧啶(5-Fu)和顺铂(DDP)联合化疗治疗晚期胃癌的疗效和不良反应。
3.
The adjuvant chemotherapy (AC) with leucovorin/5- fluorouracil (LV/5-FU) was carried out within two weeks after radical operation.
在手术后2周内开始予以LV／5-FU(甲酰四氢叶酸／5-氟尿嘧啶)辅助化疗。
6) CF
甲酰四氢叶酸钙
1.
Evaluation of 5-Fluorouracil(5-Fu) Combined with Calcium Formyltetrahydrofolate (CF) for the Treatment of Liver Metastatic Tumor;
5-氟脲嘧啶和甲酰四氢叶酸钙联合治疗肝转移瘤的疗效评价
2.
[Objective] To observe the efficacy and toxicity of combination chemotherapy with HCPT/CF/5Fu in advanced colorectal cancer.
d1～5,甲酰四氢叶酸钙200mgivd1～5,5-氟尿嘧啶500mg/m2ivd1～5,对照组:5F+CF用法用量同治疗组。
补充资料：甲酰四氢叶酸钙
分子式：C20H21CaN7O7
分子量：暂无
CAS号：1492-18-8
性质：暂无
制备方法：暂无
用途：用于解除氨基喋呤及甲氨喋呤过量而引起的毒性反应，还可用于治疗巨型红细胞贫血。
分子量：暂无
CAS号：1492-18-8
性质：暂无
制备方法：暂无
用途：用于解除氨基喋呤及甲氨喋呤过量而引起的毒性反应，还可用于治疗巨型红细胞贫血。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条